Bank of America’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $112M | Sell |
|
|||||
|
2025
Q2 | $83.9M | Buy |
|
|||||
|
2025
Q1 | $81.5M | Buy |
|
|||||
|
2024
Q4 | $67.2M | Buy |
|
|||||
|
2024
Q3 | $45.6M | Sell |
|
|||||
|
2024
Q2 | $67.1M | Buy |
|
|||||
|
2024
Q1 | $30.2M | Sell |
|
|||||
|
2023
Q4 | $26.6M | Buy |
|
|||||
|
2023
Q3 | $16M | Buy |
|
|||||
|
2023
Q2 | $8.82M | Sell |
|
|||||
|
2023
Q1 | $12.9M | Sell |
|
|||||
|
2022
Q4 | $26.9M | Buy |
|
|||||
|
2022
Q3 | $2.62M | Buy |
|
|||||
|
2022
Q2 | $742K | Sell |
|
|||||
|
2022
Q1 | $4.35M | Buy |
|
|||||
|
2021
Q4 | $3.25M | Buy |
|
|||||
|
2021
Q3 | $377K | Sell |
|
|||||
|
2021
Q2 | $478K | Sell |
|
|||||
|
2021
Q1 | $691K | Buy |
|
|||||
|
2020
Q4 | $585K | Sell |
|
|||||
|
2020
Q3 | $846K | Sell |
|
|||||
|
2020
Q2 | $3.57M | Buy |
|
|||||
|
2020
Q1 | $406K | Sell |
|
|||||
|
2019
Q4 | $580K | Sell |
|
|||||
|
2019
Q3 | $796K | Sell |
|
|||||
|
2019
Q2 | $2.65M | Sell |
|
|||||
|
2019
Q1 | $5.25M | Buy |
|
|||||
|
2018
Q4 | $842K | Buy |
|
|||||
|
2018
Q3 | $600K | Sell |
|
|||||
|
2018
Q2 | $2.5M | Buy |
|
|||||
|
2018
Q1 | $807K | Buy |
|
|||||
|
2017
Q4 | $159K | Buy |
|
|||||
|
2017
Q3 | $42K | Sell |
|
|||||
|
2017
Q2 | $25K | Buy |
|
|||||
|
2017
Q1 | $1K | Hold |
|
|||||
|
2016
Q4 | $1K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $10K | Buy |
|
|||||
|
2016
Q1 | $1K | Sell |
|
|||||
|
2015
Q4 | $4K | Buy |
|
|||||
|
2015
Q3 | $8K | Sell |
|
|||||
|
2015
Q2 | $30K | Buy |
|
|||||
|
2015
Q1 | $14K | Sell |
|
|||||
|
2014
Q4 | $89K | Sell |
|
|||||
|
2014
Q3 | $177K | Buy |
|
|||||
|
2014
Q2 | $168K | Buy |
|
|||||
|
2014
Q1 | $10K | Sell |
|
|||||
|
2013
Q4 | $55K | Buy |
|
|||||
|
2013
Q3 | $16K | Sell |
|
|||||
|
2013
Q2 | $190K | Buy |
|